Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 21 tags : Als save search
Commencement of Phase 2 Mechanical Sorter Trials at Nullagine Gold Project
Published: 2021-12-21 (Crawled : 01:00) - globenewswire.com
NSRPF | $0.1137 10.0% 24K
|
Non-Energy Minerals
|
| O: 6.19%
H: 0.0%
C: -3.2%
phase 2 als trials trial
Global Industrial Wastewater Treatment Chemicals Market (2021 to 2026) - Increase in the Demand for Specific Formulations Presents Opportunities
Published: 2021-12-21 (Crawled : 23:00) - prnewswire.com
PNR 4 | $78.99 0.66% 0.0% 2M
|
Producer Manufacturing
|
| O: 0.28%
H: 0.51%
C: -0.61%
ECL | News | $220.78 0.51% 0.0% 710K
|
Process Industries
|
| O: -0.19%
H: 1.04%
C: 0.79%
IOSP | $122.09 -0.7% -0.7% 74K
|
Process Industries
|
| O: -0.23%
H: 0.64%
C: 0.24%
treatment ema als trial
Eiger BioPharmaceuticals Announces First Patient Enrolled in LIMT-2: A Phase 3 Study of Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection
Published: 2021-12-21 (Crawled : 22:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 1.09%
H: 0.54%
C: -2.52%
hepatitis als biopharma infection phase 3 enroll infections
Nexstar Media Charitable Foundation Donates $5,000 To The Easter Seals Rehabilitation Center Of Wheeling, West Virginia
Published: 2021-12-21 (Crawled : 19:00) - nexstar.tv
NXST | News | $164.055 0.58% 0.58% 210K
|
Consumer Services
|
| O: 0.05%
H: 1.05%
C: 0.47%
als star media
Chubb and Wharton Study Examines Ultra-High-Net-Worth Individuals' Preferences on Financial Advising and Investment Management
Published: 2021-12-21 (Crawled : 15:30) - prnewswire.com
CB | News | $243.01 -2.75% 0.16% 3.2M
|
Finance
|
| O: 1.07%
H: 0.78%
C: -0.27%
als
New Report Reveals Gen Z Candidates Expect Open Communication and Diversity, Equity and Inclusion Focus from Prospective Employers
Published: 2021-12-21 (Crawled : 15:00) - fadv.com
FA | $16.435 0.15% 0.15% 510K
|
Professional, Scientific, and T...
|
| O: 0.66%
H: 4.21%
C: 3.98%
als communication
TFF Pharmaceuticals Announces Final Data from Phase 1b Study of Inhaled Voriconazole Powder in Asthma Patients
Published: 2021-12-21 (Crawled : 15:00) - biospace.com/
TFFP | $3.04 2.36% 2.3% 13K
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: -1.84%
als phase 1b phase 1 phase 2b
Titan Pharmaceuticals to Explore Strategic Alternatives
Published: 2021-12-21 (Crawled : 14:30) - biospace.com/
TTNP | $7.01 0.57% 2.6K
|
Health Technology
|
| O: 10.28%
H: 23.73%
C: 11.02%
als alternative
Univar Solutions Expands its Ingredients & Specialties Portfolio through New Distribution Agreement for Kalsec's Natural Taste & Sensory Solutions, Colours and Antioxidants
Published: 2021-12-21 (Crawled : 13:30) - prnewswire.com
UNVR | $36.14 0.47% 0.0% 0
|
Distribution Services
|
| O: 1.29%
H: 1.35%
C: 0.49%
als sensor distribution
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver Cancer
Published: 2021-12-21 (Crawled : 13:00) - hepionpharma.com
HEPA | $1.39 -6.71% -7.19% 37K
|
Health Technology
|
| O: 0.83%
H: 7.38%
C: 0.82%
crv431 treatment fda als clearance application liver fda clearance cancer
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
Published: 2021-12-21 (Crawled : 12:30) - biospace.com/
ANIP S | $65.375 -1.16% -1.17% 83K
|
Health Technology
|
| O: 1.79%
H: 0.38%
C: 0.33%
fda als fda approval approval
IMV Announces Finalization of the Basket Clinical Study in Collaboration with Merck and Reveals Promising Top Line Data from the Bladder and MSI-High Cohorts
Published: 2021-12-21 (Crawled : 12:30) - biospace.com/
IMV | $0.8225 -2.74% 45K
|
Health Technology
|
| O: 0.78%
H: 13.18%
C: 11.63%
als collaboration topline bladder
NovaBay Pharmaceuticals Holds Special Meeting of Stockholders
Published: 2021-12-21 (Crawled : 12:30) - biospace.com/
NBY | $0.0773 0.39% 0.0% 920K
|
Health Technology
|
| O: -0.67%
H: 3.44%
C: 0.81%
als
Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS, and the Common Cold Human Coronaviruses
Published: 2021-12-21 (Crawled : 11:00) - prnewswire.com
ARDS | $0.0635 2.82% 150K
|
Health Technology
|
| O: 60.24%
H: 6.63%
C: -31.7%
covid-19 als covid antibody
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.